Literature DB >> 19254937

A centralized informatics infrastructure for the National Institute on Drug Abuse Clinical Trials Network.

Jeng-Jong Pan1, Meredith Nahm, Paul Wakim, Carol Cushing, Lori Poole, Betty Tai, Carl F Pieper.   

Abstract

BACKGROUND: Clinical trial networks (CTNs) were created to provide a sustaining infrastructure for the conduct of multisite clinical trials. As such, they must withstand changes in membership. Centralization of infrastructure including knowledge management, portfolio management, information management, process automation, work policies, and procedures in clinical research networks facilitates consistency and ultimately research.
PURPOSE: In 2005, the National Institute on Drug Abuse (NIDA) CTN transitioned from a distributed data management model to a centralized informatics infrastructure to support the network's trial activities and administration. We describe the centralized informatics infrastructure and discuss our challenges to inform others considering such an endeavor.
METHODS: During the migration of a clinical trial network from a decentralized to a centralized data center model, descriptive data were captured and are presented here to assess the impact of centralization.
RESULTS: We present the framework for the informatics infrastructure and evaluative metrics. The network has decreased the time from last patient-last visit to database lock from an average of 7.6 months to 2.8 months. The average database error rate decreased from 0.8% to 0.2%, with a corresponding decrease in the interquartile range from 0.04%-1.0% before centralization to 0.01-0.27% after centralization. Centralization has provided the CTN with integrated trial status reporting and the first standards-based public data share. A preliminary cost-benefit analysis showed a 50% reduction in data management cost per study participant over the life of a trial. LIMITATIONS: A single clinical trial network comprising addiction researchers and community treatment programs was assessed. The findings may not be applicable to other research settings.
CONCLUSIONS: The identified informatics components provide the information and infrastructure needed for our clinical trial network. Post centralization data management operations are more efficient and less costly, with higher data quality.

Entities:  

Mesh:

Year:  2009        PMID: 19254937      PMCID: PMC2962616          DOI: 10.1177/1740774508100983

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  22 in total

1.  Data management procedures in the Asthma Clinical Research Network.

Authors:  R M Pogash; S J Boehmer; P E Forand; A M Dyer; S J Kunselman
Journal:  Control Clin Trials       Date:  2001-12

2.  Application of quality improvement theory and process in a national multicenter HIV/AIDS clinical trials network.

Authors:  Jack Rouff; Carroll Child
Journal:  Qual Manag Health Care       Date:  2003 Apr-Jun       Impact factor: 0.926

Review 3.  Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG).

Authors:  Diana M Escolar; Erik K Henricson; Livia Pasquali; Ksenija Gorni; Eric P Hoffman
Journal:  Neuromuscul Disord       Date:  2002-10       Impact factor: 4.296

4.  The NHLBI COPD clinical research network.

Authors:  Richard K Albert
Journal:  Pulm Pharmacol Ther       Date:  2004       Impact factor: 3.410

5.  External monitoring of a data coordinating center: experience of the National Cooperative Gallstone Study.

Authors:  P L Canner; L C Gatewood; C White; J M Lachin; L J Schoenfield
Journal:  Control Clin Trials       Date:  1987-03

6.  Functional equality of coordinating centers in a multicenter clinical trial. Experience of the International Mexiletine and Placebo Antiarrhythmic Coronary Trial (IMPACT).

Authors:  Y Alamercery; P Wilkins; T Karrison
Journal:  Control Clin Trials       Date:  1986-03

7.  Promoting interactions with basic scientists and clinicians: the NIA Alzheimer's Disease Data Coordinating Center.

Authors:  D Cronin-Stubbs; S T DeKosky; J C Morris; D A Evans
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

Review 8.  The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases.

Authors:  C H Goss; N Mayer-Hamblett; R A Kronmal; B W Ramsey
Journal:  Adv Drug Deliv Rev       Date:  2002-12-05       Impact factor: 15.470

9.  The Child and Adolescent Psychiatry Trials Network (CAPTN).

Authors:  John S March; Susan G Silva; Scott Compton; Ginger Anthony; Joseph DeVeaugh-Geiss; Robert Califf; Ranga Krishnan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-05       Impact factor: 8.829

10.  Quantifying data quality for clinical trials using electronic data capture.

Authors:  Meredith L Nahm; Carl F Pieper; Maureen M Cunningham
Journal:  PLoS One       Date:  2008-08-25       Impact factor: 3.240

View more
  3 in total

1.  The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment.

Authors:  Betty Tai; Michele M Straus; David Liu; Steven Sparenborg; Ron Jackson; Dennis McCarty
Journal:  J Subst Abuse Treat       Date:  2010-06

2.  NeuroBlu, an electronic health record (EHR) trusted research environment (TRE) to support mental healthcare analytics with real-world data.

Authors:  Rashmi Patel; Soon Nan Wee; Rajagopalan Ramaswamy; Simran Thadani; Jesisca Tandi; Ruchir Garg; Nathan Calvanese; Matthew Valko; A John Rush; Miguel E Rentería; Joydeep Sarkar; Scott H Kollins
Journal:  BMJ Open       Date:  2022-04-22       Impact factor: 3.006

3.  Toward an open-access global database for mapping, control, and surveillance of neglected tropical diseases.

Authors:  Eveline Hürlimann; Nadine Schur; Konstantina Boutsika; Anna-Sofie Stensgaard; Maiti Laserna de Himpsl; Kathrin Ziegelbauer; Nassor Laizer; Lukas Camenzind; Aurelio Di Pasquale; Uwem F Ekpo; Christopher Simoonga; Gabriel Mushinge; Christopher F L Saarnak; Jürg Utzinger; Thomas K Kristensen; Penelope Vounatsou
Journal:  PLoS Negl Trop Dis       Date:  2011-12-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.